<DOC>
	<DOCNO>NCT01255956</DOCNO>
	<brief_summary>The aim study compare rapamycin elute stent paclitaxel elute balloon catheter treatment restenosis bare metal stent .</brief_summary>
	<brief_title>Restenosis Treatment With Rapamycin Eluting Stent Paclitaxel Eluting Balloon Catheter ( RESTENOZA )</brief_title>
	<detailed_description>Study aim : - Clinical efficacy evaluation different treatment 's strategy , include periprocedural long-term endpoint define : death , myocardial infarction , brain stroke , necessity repeat revascularization - Evaluation intravascular ultrasound ( IVUS ) optimisation method direct long-term revascularization effect - Evaluation optical coherence tomography optimisation method direct long-term revascularization effect - Evaluation late lumen loss neointimal hyperplasia stent long-term follow-up - Analysis direct indirect medical cost alternative treatment strategy Study group : 200 patient symptomatic restenosis evidence angiographically bare metal stent implant native coronary artery . Patients randomise 2 therapeutic group : - Patients treat rapamycin elute stent ( n=100 ) - Patients treat paclitaxel elute balloon catheter ( n=100 )</detailed_description>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>least 18 year age symptomatic restenosis bare metal stent implant native coronary artery angina pectoris ischemia evidence noninvasive diagnostic test angiographically evidence instent restenosis &gt; 50 % assessed quantitative coronary angiography ( QCA ) vessel diameter &gt; 2,5 mm Clinical exclusion criterion : myocardial infarction within less past 72 hour heart failure leave ventricular ejection fraction ( LVEF ) &lt; 30 % chronic renal failure significant impairment glomerular filtration ( creatinine &gt; 2 mg/dl ) hypersensitivity contraindication acetylsalicylic acid , clopidogrel , heparin , abciximab , rapamycin , paclitaxel hypersensitivity contrast disease may cause significant deterioration longterm prognosis acute chronic inflammatory diseases patient unwilling consent participation study Angiographic exclusion criterion : significant stenosis leave main coronary artery ( LM ) multivessel disease qualify coronary artery bypass grafting ( CABG ) anatomical localization morphology preclude optimal percutaneous intervention intervention 's ( PCI ) result intravascular ultrasound ( IVUS ) optical coherence tomography performance vessel diameter &lt; 2,5 mm restenotic lesion length &gt; 30 mm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>restenosis</keyword>
	<keyword>ISR</keyword>
	<keyword>in-stent restenosis</keyword>
	<keyword>drug elute stent</keyword>
	<keyword>rapamycin elute stent</keyword>
	<keyword>paclitaxel elute balloon catheter</keyword>
</DOC>